Neupharma Srl: Clinical Trials

1 trial sponsored by Neupharma Srl, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Neupharma Srl: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. - Cystic Fibrosis
Phase 1CompletedNeupharma Srl122019-10-252020-12-09

Conditions studied

Cystic Fibrosis (1)

Interventions

Injections (1)  ·  Powders (1)  ·  Solutions (1)  ·  Solvents (1)  ·  Teicoplanin (1)

Countries

Italy (1)

Top investigators

Giulia Paiola, MD (1)